Margarita Matías‐Florentino

Author

Also Known As

M. Matías-Florentino, Margarita Matias-Florentino, Margarita Matías-Florentino, Margarita Matías‐Florentino, Maribel Soto-Nava, Matías-Florentino, Margarita

Publications

646

Citations

H-Index

Concepts

All Affiliations

Universidad Nacional Autónoma de México Instituto Nacional de Enfermedades Respiratorias Mexican Social Security Institute Institute of Ophthalmology Instituto Politécnico Nacional

About

Margarita Matías‐Florentino is an author at Universidad Nacional Autónoma de México specializing in medicine, epidemiology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	224
2	Public Health	2	2	147
3	Engineering	1	1	42
4	Natural Sciences	1	1	20
5	Cell Biology	1	1	42

Margarita Matías‐Florentino

Publications

605

Citations

H-Index

Page 1

	Year	Citations
Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey Santiago Ávila‐Ríos, Claudia García‐Morales, Margarita Matías‐Florentino, The Lancet HIV Pretreatment Hiv-drug ResistanceWho SurveySubstance AbusePreventive MedicineRepresentative 2015	2016	103
Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes Alejandra Hernández‐Terán, Fidencio Mejía-Nepomuceno, María Teresa Alarcón Herrera, Scientific Reports	2021	81
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping Neil Parkin, Santiago Ávila‐Ríos, David Bibby, Viruses	2020	47
Genetic Analysis of SARS-CoV-2 Variants in Mexico during the First Year of the COVID-19 Pandemic Blanca Taboada, Selene Zárate, Pavel Iša, Viruses Virus EpidemiologyViral DiagnosticsGenetic EpidemiologyGenomicsCovid-19 Epidemiology	2021	44
Gene Therapy for Retinitis Pigmentosa Caused by <i>MFRP</i> Mutations: Human Phenotype and Preliminary Proof of Concept Astra Dinculescu, Jackie Estreicher, Juan Carlos Zenteno, Human Gene Therapy Ocular DiseaseEngineeringIn Vivo Gene TherapyRobust Mfrp ExpressionPathology	2011	42
Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico Abril Paulina Rodríguez-Maldonado, Joel Armando Vázquez-Pérez, Alberto Cedro‐Tanda, Archives of Virology	2021	38
The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico Selene Zárate, Blanca Taboada, José Esteban Muñoz‐Medina, Microbiology Spectrum	2022	36
Contribution of CYP1B1 Mutations and Founder Effect to Primary Congenital Glaucoma in Mexico Juan Carlos Zenteno, Elena Hernandez‐Merino, Herlinda Mejía-López, Journal of Glaucoma	2008	26
Pretreatment HIV drug resistance spread within transmission clusters in Mexico City Margarita Matías‐Florentino, Antoine Chaillon, Santiago Ávila‐Ríos, Journal of Antimicrobial Chemotherapy	2019	23
Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico Blanca Taboada, Selene Zárate, Rodrigo García-López, Viruses Virus EpidemiologySars-cov-2 Delta VariantDelta VariantCentral MexicoCovid-19	2022	20

Page 1